RecruitingNCT02594202

Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue


Sponsor

National Cancer Institute (NCI)

Enrollment

3,000 participants

Start Date

Dec 21, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Prostate cancer is the most common noncutaneous cancer among men in the U.S. Researchers want to study blood, tissue, and fluid samples of people with prostate cancer. This will help them understand any changes in cells and genes. These changes might lead to the development and progression of prostate cancer. Researchers think the study could lead to new treatments. Objective: To understand the changes in cells and genes that lead to the development and progression of prostate cancer. This could lead to new treatments. Eligibility: Men ages 18 and older who have or are suspected to have prostate cancer Design: Participants will be screened with physical exam and medical history. Participants will send tissue blocks of their tumor, if possible. If not, they will provide unstained slides of tumor tissue. Participants may provide samples of blood, urine, saliva, and prostate secretions. Participants may have imaging tests. They will lie in a machine that takes pictures of their body. These tests include: MRI of the prostate CT of the abdomen and pelvis Chest x-ray Participants may need a biopsy or surgery for treatment of their cancer. If so, researchers will collect tissue. Participants may answer questions about their prostate cancer and quality of life. Participants may have follow-up visits or other treatments. They may have follow-up phone calls every few months. ...


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study at the NIH collects tissue samples, blood, and clinical data from men with known or suspected prostate cancer who are undergoing standard diagnostic or treatment procedures, to help researchers better understand the disease and develop improved tests and therapies. **You may be eligible if...** - You are 18 years of age or older - You have biopsy-proven prostate cancer, or your doctor suspects prostate cancer based on an elevated PSA, abnormal rectal exam, abnormal prostate MRI, or family history - You are already scheduled for a diagnostic or therapeutic procedure as part of your standard care - You are in good enough health to undergo the procedure (ECOG performance status 0-2) - Your PSA is above 1.0 ng/ml (if aged 30-49) or above 2.5 ng/ml (if aged 50+), or you have a concerning rectal exam, MRI finding, or family history of prostate, breast, or ovarian cancer **You may NOT be eligible if...** - Your other health conditions would prevent you from safely undergoing the required procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02594202


Related Trials